Irreversible electroporation (IRE)

Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

Prostate Cancer IRE Study (PRIS)

Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic Cancer

CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With Radiotherapy

Efficacy of Irreversible Electroporation (IRE) for Central Colorectal Liver Metastases

Pilot-study: Non-thermal Ablation Using Irreversible Electroporation to Treat Colorectal Liver Metastases

PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer

Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate Cancer

Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome

Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms

Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis Neoplasms

Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms

Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency

Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms

Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms

Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms

Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms

Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms

Irreversible Electroporation(IRE) For Unresectable Lymph Node Metastases(Close to Nerve)

Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms